Anti-CD3 Monoclonal Antibody | Clinical Trials Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

29,019 results for “Anti-CD3 Monoclonal Antibody”

Need more precision?

Filter by phase, recruitment status, country, sponsor, age, and study type.

Refine trial search

Oral Administration of Anti-CD3 Monoclonal Antibody in Non-responder Genotype-I Chronic Hepatitis C Subjects

36 participants · First posted Oct 25, 2011

Safety and Efficacy of Oral Administration of Anti-CD3 Monoclonal Antibody (mAb)in Patients With the Metabolic Syndrome

36 participants · First posted Sep 20, 2010

A Study of REGN7041 for Active Noninfectious Uveitis in Adult Participants

1 participants · First posted Oct 20, 2025

Safety, Tolerability and Immune Effects of the Nasal Foralumab in Healthy Human Volunteers

27 participants · First posted Mar 17, 2025

A Study of Oral Foralumab in Participants With Moderate to Severely Active Crohn's Disease

First posted Aug 31, 2021

Phase 1b Multiple Ascending Dose Study of Foralumab in Primary and Secondary Progressive MS

First posted Aug 31, 2021

Intermediate-Size Patient Population Expanded Access: Foralumab in Non-Active Secondary Progressive MS Patients

First posted Jan 31, 2025

Protege Extension Trial - Long Term Follow Up Trial for Subjects Who Completed the Protege Study (CP-MGA031-01)

219 participants · First posted Mar 27, 2009

Protege Encore Study- Clinical Trial of Teplizumab (MGA031) in Children and Adults With Recent-Onset Type 1 Diabetes Mellitus

254 participants · First posted Jun 15, 2009

Active, not recruiting

Recent-Onset Type 1 Diabetes Extension Study Evaluating the Long-Term Safety of Teplizumab (PROTECT Extension)

188 participants · First posted Oct 22, 2020

Page 1 of 1396